| DC Field | Value | Language |
|---|
| dc.contributor.author | Baihao Mei | - |
| dc.contributor.author | Ying Li | - |
| dc.contributor.author | Zhaoyu Gao | - |
| dc.date.accessioned | 2026-10-13T08:45:37Z | - |
| dc.date.available | 2026-10-13T08:45:37Z | - |
| dc.date.issued | 2026 | - |
| dc.identifier.citation | Baihao Mei. Designing siRNA nanocarriers for myocardial ischemia/reperfusion injury: pathobiological targets, delivery barriers, platform strategies, and translational constraints / Mei Baihao, Li Ying, Gao Zhaoyu // Research Results in Pharmacology. - 2026. - Vol.12, №3.-P. 104-117. - DOI: 10.18413/rrpharmacology.12.1206. - Refer.: p. 114-117. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/67140 | - |
| dc.description.abstract | The central message of this review is that carrier design should begin with the delivery barrier, not with the material category - and that for the heart, the barrier chain includes microvascular obstruction and endothelial permeability as an independent access step that platform-organized reviews have not yet treated as a design variable | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | cardiac drug delivery | ru |
| dc.subject | endosomal escape | ru |
| dc.subject | evidence maturity | ru |
| dc.subject | ischemia/reperfusion injury | ru |
| dc.subject | microvascular obstruction | ru |
| dc.subject | nanocarrier | ru |
| dc.title | Designing siRNA nanocarriers for myocardial ischemia/reperfusion injury: pathobiological targets, delivery barriers, platform strategies, and translational constraints | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 12, № 3
|
